The Australian Melanoma Research Foundation (AMRF) is thrilled to announce the corporate partnership with executive search firm, Fish Nankivell.
Established in 1984, Fish Nankivell is one of Australia’s most enduring and highly respected executive search firms. Fully Australian owned, Fish Nankivell holds a vested interest in building trusted and sustainable business relationships through their expertise as search and advisory specialists.
Tori Best, Managing Partner of Fish Nankivell is committed to not only honouring the legacy of co-founder Greg Fish, who sadly passed away of melanoma, but aims to provide ongoing support through their work to support their appointed charities. The chosen charitable organisations hold direct links to the values and legacy held by the firm.
Commencing July 2023, Fish Nankivell launched their ‘make a difference’ charity initiative and have agreed to pledge a percentage of all placement fees to one of just three appointed charities, including AMRF. The concept allows their clients who engage Fish Nankivell professionally, to choose where they would like the percentage of their fee to go.
You can learn more about Fish Nankivell’s ‘make a difference’ initiative, including viewing the monies donated, by visiting www.fishnankivell.com/social-impact.
Thank you, Fish Nankivell. Together we can make a difference to Australians impacted by melanoma.
On Monday 6 November, Fish Nankivell presented the AMRF with their first cheque. All funds raised will go towards invaluable research, typically awarded to young graduates keen to apply their learnings towards finding more pathways and treatment options. The shocking effects of melanoma in Australia are well documented, reinforcing the need for investment into research, early detection, and promoting awareness.
We wish to thank Tori Best and Fish Nankivell for their support and being part of the life-changing work we do.